Admetsys is an innovative biomedical technology company that has developed the world's first artificial pancreas system for use in hospital and surgical care. Admetsys' treatment technology and supplementary remote monitoring products provide hospitals with full automation of glucose monitoring and treatment, significantly advancing the standard of diabetic control, and offering the precision and repeatability required by hospitals worldwide for this critical aspect of patient care.
